Startups
The Accelerating Therapeutics for Opportunities in Medicine (ATOM) consortium is a public-private partnership with the mission accelerating the development of more effective therapies for patients. Our goal is to transform drug discovery from a slow, sequential, and high-failure process into a rapid, integrated, and patient-centric model. We are integrating high performance computing, diverse biological data, and emerging biotechnologies to create a new pre-competitive platform for drug discovery.
Overview
Location
United States, California, San Francisco
Employees
11-50
Founded date
2017
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Nvidia’s plan to take the ‘anxiety’ out of AI’s use in radiology | Much of the media attention around AI in radiology has had a bit of a Terminator tilt to it. Headlines based on the primacy of AI algorithms in detecting potential issues are often paired with the conclusion that radiologists are quickly be... |
Reviews 0
FAQ about Atom
When was Atom founded?
Atom was founded in 2017.
What has the press written about Atom?
Parsers VC has collected 2 articles mentioning Atom, among them “Nvidia’s plan to take the ‘anxiety’ out of AI’s use in radiology”.
Is Atom still active?
Yes, Atom is active; its latest activity on Parsers VC dates from Apr 9, 2019.